Senate Bill 566
2019-2020 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions, providing for Pennsylvania Safe and Effective Opioid Prescribing Advisory Council and further providing for promulgation of regulations.
Co-Sponsorship Memo
Prime Sponsor
Senator Gene Yaw
R Senate District 23
Co-Sponsors
Sen. Joseph Scarnati
R Senate District 25
Sen. Camera Bartolotta
R Senate District 46
Sen. James Brewster
D Senate District 45
Sen. Patrick Stefano
R Senate District 32
Sen. Bob Mensch
R Senate District 24
Sen. Lisa Baker
R Senate District 20
Sen. Mario Scavello
R Senate District 40
Sen. Thomas Killion
R Senate District 9
Sen. Jay Costa
D Senate District 43
Sen. John Yudichak
I Senate District 14
Sen. Patrick Browne
R Senate District 16
Sen. Art Haywood
D Senate District 4
Bill Status & History
Last Action: Referred to Health & Human Services, April 18, 2019
Senate
S
H
| 0628 | Referred to Health & Human Services, April 18, 2019 |
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.
Sen. Kim Ward
R Senate District 39
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The
Senate Bill 566
2019-2020 Regular Session
Sponsors
YAW, SCARNATI, BARTOLOTTA, BREWSTER, STEFANO, MENSCH, BAKER, SCAVELLO, KILLION, COSTA, YUDICHAK, BROWNE, HAYWOOD
Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions, providing for Pennsylvania Safe and Effective Opioid Prescribing Advisory Council and further providing for promulgation of regulations.
Memo Subject
Implementation of Opioid Prescribing Guidelines
Actions
| 0628 | Referred to HEALTH AND HUMAN SERVICES, April 18, 2019 |
Generated 05/14/2025 03:07 PM